| Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis F Ceban, S Ling, LMW Lui, Y Lee, H Gill, KM Teopiz, NB Rodrigues, ... Brain, behavior, and immunity 101, 93-135, 2022 | 893 | 2022 |
| Bipolar disorders E Vieta, M Berk, TG Schulze, AF Carvalho, T Suppes, JR Calabrese, ... Nature reviews Disease primers 4 (1), 1-16, 2018 | 705 | 2018 |
| Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables KW Miskowiak, S Johnsen, SM Sattler, S Nielsen, K Kunalan, J Rungby, ... European Neuropsychopharmacology 46, 39-48, 2021 | 347 | 2021 |
| Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses B Bortolato, KW Miskowiak, CA Köhler, E Vieta, AF Carvalho Neuropsychiatric disease and treatment, 3111-3125, 2015 | 301 | 2015 |
| Cognitive remission: a novel objective for the treatment of major depression? B Bortolato, KW Miskowiak, CA Köhler, M Maes, BS Fernandes, M Berk, ... BMC medicine 14, 1-18, 2016 | 265 | 2016 |
| Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force KW Miskowiak, KE Burdick, A Martinez‐Aran, CM Bonnin, CR Bowie, ... Bipolar Disorders 19 (8), 614-626, 2017 | 173 | 2017 |
| Is there an association between subjective and objective measures of cognitive function in patients with affective disorders? AM Svendsen, LV Kessing, K Munkholm, M Vinberg, KW Miskowiak Nordic journal of psychiatry 66 (4), 248-253, 2012 | 142 | 2012 |
| Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians KW Miskowiak, KE Burdick, A Martinez‐Aran, CM Bonnin, CR Bowie, ... Bipolar disorders 20 (3), 184-194, 2018 | 141 | 2018 |
| The Bipolar Illness Onset study: research protocol for the BIO cohort study LV Kessing, K Munkholm, M Faurholt-Jepsen, KW Miskowiak, LB Nielsen, ... BMJ open 7 (6), e015462, 2017 | 135 | 2017 |
| Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: associations with functional abilities JH Jensen, U Knorr, M Vinberg, LV Kessing, KW Miskowiak Journal of affective disorders 205, 378-386, 2016 | 131 | 2016 |
| Erythropoietin enhances hippocampal response during memory retrieval in humans K Miskowiak, U O'Sullivan, CJ Harmer Journal of Neuroscience 27 (11), 2788-2792, 2007 | 130 | 2007 |
| Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools CV Ott, AJ Bjertrup, JH Jensen, H Ullum, R Sjælland, SE Purdon, E Vieta, ... Journal of Affective Disorders 190, 607-615, 2016 | 124 | 2016 |
| Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial KW Miskowiak, M Vinberg, EM Christensen, JD Bukh, CJ Harmer, ... Neuropsychopharmacology 39 (6), 1399-1408, 2014 | 124 | 2014 |
| Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence TE Van Rheenen, KE Lewandowski, IE Bauer, F Kapczinski, K Miskowiak, ... Bipolar disorders 22 (1), 13-27, 2020 | 123 | 2020 |
| Cognitive dysfunction in depression–pathophysiology and novel targets A F Carvalho, K K Miskowiak, T N Hyphantis, C A Kohler, G S Alves, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 119 | 2014 |
| Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin D Wakhloo, F Scharkowski, Y Curto, U Javed Butt, V Bansal, ... Nature Communications 11 (1), 1313, 2020 | 116 | 2020 |
| Optimising screening for cognitive dysfunction in bipolar disorder: validation and evaluation of objective and subjective tools JH Jensen, MM Støttrup, E Nayberg, U Knorr, H Ullum, SE Purdon, ... Journal of Affective Disorders 187, 10-19, 2015 | 116 | 2015 |
| Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration K Miskowiak, B Inkster, S Selvaraj, R Wise, GM Goodwin, CJ Harmer Neuropsychopharmacology 33 (3), 611-618, 2008 | 104 | 2008 |
| Effects of short-term cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: results of a randomised controlled trial KM Demant, M Vinberg, LV Kessing, KW Miskowiak PLoS One 10 (6), e0127955, 2015 | 103 | 2015 |
| Effects of erythropoietin on hippocampal volume and memory in mood disorders KW Miskowiak, M Vinberg, J Macoveanu, H Ehrenreich, N Køster, ... Biological psychiatry 78 (4), 270-277, 2015 | 102 | 2015 |
